Despite this, recent studies using large language models to analyze public sentiment suggest that most opinions about GLP-1R-based weight loss treatments are either positive or neutral (Somani et al., 2024)
The Cancer Biology Connection The concern about BPC-157 and malignancy stems from a biological reality: the same pathways enabling tissue repair are exploited by cancer cells for growth, survival, and metastatic spread
Can I stop one GLP-1 today and start another tomorrow
Some former compounding patients are turning to questionable online sellers operating on shaky legal footing
I recently discussed all this and more with Tina Vilsbll, Professor at the University of Copenhagen and Research Leader at the Steno Diabetes Centre, and Michael Wagner, Senior VP, Chemistry & Drug Discovery at Dewpoint Therapeutics and Co-founder of Antaros Tracer, in a webinar called The Incretin Impact: a new era in metabolic disease and obesity drug development
T.MokhosoevI